182 related articles for article (PubMed ID: 37639032)
21. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839
[TBL] [Abstract][Full Text] [Related]
22. Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
Dhir M; Jones HL; Shuai Y; Clifford AK; Perkins S; Steve J; Hogg ME; Choudry MH; Pingpank JF; Holtzman MP; Zeh HJ; Bahary N; Bartlett DL; Zureikat AH
Ann Surg Oncol; 2017 Jan; 24(1):150-158. PubMed ID: 27431415
[TBL] [Abstract][Full Text] [Related]
23. Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
Bolton JS; O'Connell MJ; Mahoney MR; Farr GH; Fitch TR; Maples WJ; Nagorney DM; Rubin J; Fuloria J; Steen PD; Alberts SR
Clin Colorectal Cancer; 2012 Mar; 11(1):31-7. PubMed ID: 21729678
[TBL] [Abstract][Full Text] [Related]
24. Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy.
Pilati P; Mammano E; Mocellin S; Tessari E; Lise M; Nitti D
Anticancer Res; 2009 Oct; 29(10):4139-44. PubMed ID: 19846962
[TBL] [Abstract][Full Text] [Related]
25. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D
Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
[TBL] [Abstract][Full Text] [Related]
26. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.
Mocellin S; Pasquali S; Nitti D
Cochrane Database Syst Rev; 2009 Jul; (3):CD007823. PubMed ID: 19588444
[TBL] [Abstract][Full Text] [Related]
27. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy.
Meric F; Patt YZ; Curley SA; Chase J; Roh MS; Vauthey JN; Ellis LM
Ann Surg Oncol; 2000 Aug; 7(7):490-5. PubMed ID: 10947016
[TBL] [Abstract][Full Text] [Related]
28. Hepatic arterial infusion chemotherapy for colorectal liver metastases revisited.
Chouliaras K; Russell G; Levine E; Howerton R; Votanopoulos K; Clark C; Shen P
HPB (Oxford); 2020 Sep; 22(9):1265-1270. PubMed ID: 31959486
[TBL] [Abstract][Full Text] [Related]
29. Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review.
Link KH; Kornmann M; Formentini A; Leder G; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Langenbecks Arch Surg; 1999 Aug; 384(4):344-53. PubMed ID: 10473854
[TBL] [Abstract][Full Text] [Related]
30. Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial.
Malka D; Verret B; Faron M; Guimbaud R; Caramella C; Edeline J; Galais MP; Bengrine-Lefevre L; Smith D; Dupont-Bierre E; De Baere T; Goéré D; Dartigues P; Lacroix L; Boige V; Gelli M; Pignon JP; Ducreux M
Eur J Cancer; 2023 Dec; 195():113400. PubMed ID: 37922632
[TBL] [Abstract][Full Text] [Related]
31. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
[TBL] [Abstract][Full Text] [Related]
32. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
[TBL] [Abstract][Full Text] [Related]
33. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
Seki H; Ozaki T; Shiina M
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
[TBL] [Abstract][Full Text] [Related]
34. [Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer].
Tanaka K; Kumamoto T; Nojiri K; Mori R; Matsuyama R; Takeda K; Ota M; Akiyama H; Ichikawa Y; Endo I
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2267-70. PubMed ID: 21224543
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
Martin RC; Scoggins CR; McMasters KM
J Surg Oncol; 2006 Apr; 93(5):387-93. PubMed ID: 16550574
[TBL] [Abstract][Full Text] [Related]
36. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
37. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization.
Akasu T; Moriya Y; Takayama T
Jpn J Clin Oncol; 1997 Oct; 27(5):331-5. PubMed ID: 9390211
[TBL] [Abstract][Full Text] [Related]
38. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
39. Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.
Kemeny NE; Melendez FD; Capanu M; Paty PB; Fong Y; Schwartz LH; Jarnagin WR; Patel D; D'Angelica M
J Clin Oncol; 2009 Jul; 27(21):3465-71. PubMed ID: 19470932
[TBL] [Abstract][Full Text] [Related]
40. Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
Bouchahda M; Boige V; Smith D; Karaboué A; Ducreux M; Hebbar M; Lepère C; Focan C; Guimbaud R; Innominato P; Awad S; Carvalho C; Tumolo S; Truant S; De Baere T; Castaing D; Rougier P; Morère JF; Taieb J; Adam R; Lévi F;
Eur J Cancer; 2016 Nov; 68():163-172. PubMed ID: 27768923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]